Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.51 EUR | +0.40% | +7.73% | -14.63% |
04-26 | Nexstim plc Receives Order for A New NBS System 5 from an Existing Customer Hospital in Germany | CI |
04-22 | Nexstim Wins Order for Navigated Brain Stimulation System in US | MT |
Sales 2024 * | 8.3M 8.88M 710M | Sales 2025 * | 10.8M 11.56M 924M | Capitalization | 16.91M 18.1M 1.45B |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 2.25 x |
Net Debt 2024 * | 1.8M 1.93M 154M | Net Debt 2025 * | 1.4M 1.5M 120M | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
-22.7
x | P/E ratio 2025 * |
35.7
x | Employees | 37 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 51.18% |
Latest transcript on Nexstim Plc
1 day | +0.40% | ||
1 week | +7.73% | ||
Current month | +8.19% | ||
1 month | +5.02% | ||
3 months | -0.40% | ||
6 months | +8.19% | ||
Current year | -14.63% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 47 | 17/08/14 | |
Director of Finance/CFO | 38 | 30/04/14 | |
Gustaf Järnefelt
CTO | Chief Tech/Sci/R&D Officer | 63 | 31/12/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 10/11/19 | |
Director/Board Member | 53 | 30/04/21 | |
Director/Board Member | 65 | 30/04/21 |
Date | Price | Change | Volume |
---|---|---|---|
02/05/24 | 2.51 | +0.40% | 14 847 |
30/04/24 | 2.5 | +9.17% | 44,364 |
29/04/24 | 2.29 | +1.33% | 5,146 |
26/04/24 | 2.26 | +1.35% | 8,989 |
25/04/24 | 2.23 | -3.04% | 11,321 |
Delayed Quote Nasdaq Helsinki, May 02, 2024 at 11:01 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.63% | 18.06M | |
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-2.40% | 62.09B | |
+10.56% | 50.8B | |
+4.81% | 50.88B | |
-0.24% | 40.64B | |
+1.22% | 35.71B |
- Stock Market
- Equities
- NXTMH Stock